Advertisement

The association of serum C-reactive protein with the occurrence and course of postpartum depression

  • Emily S. Miller
  • Denada Hoxha
  • Emily Pinheiro
  • William A. Grobman
  • Katherine L. Wisner
Short Communication

Abstract

CRP has been positively correlated with depressive symptomatology but this has received less study in postpartum depression (PPD). In this secondary analysis of a trial of PPD treatment, depressive symptoms (Structured Interview Guide for the Hamilton Depression Rating Scale—Atypical Depression Symptoms (SIGH-ADS29)) and serum CRP levels were assessed and associations between CRP and SIGH-ADS29 scores evaluated. The associations between baseline log CRP and depression response and remission were also assessed. Of the 35 women included, neither baseline log CRP nor exit log CRP was significantly associated with SIGH-ADS29 score. Baseline CRP was not associated with response or remission. In this sample of women with PPD, CRP was not associated with depressive symptoms nor response to treatment.

Keywords

Postpartum depression Inflammation C-reactive protein CRP 

Notes

Funding

This work was supported by the National Institutes of Health awarded to ESM (5K12HD050121-09).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. Chang HH, Lee IH, Gean PW, Lee SY, Chi MH, Yang YK, Lu RB, Chen PS (2012) Treatment response and cognitive impairment in major depression: association with C-reactive protein. Brain Behav Immun 26:90–95.  https://doi.org/10.1016/j.bbi.2011.07.239 CrossRefPubMedGoogle Scholar
  2. Chang JP, Guu TW, Chen YC, Galecki P, Walczewska A, Su KP (2017) BanI polymorphism of cytosolic phospholipase A2 gene and somatic symptoms in medication-free acute depressed patients. Prostaglandins Leukot Essent Fatty Acids.  https://doi.org/10.1016/j.plefa.2017.01.001
  3. Chang JP et al (2018) Polyunsaturated fatty acids and inflammatory markers in major depressive episodes during pregnancy. Prog Neuro-Psychopharmacol Biol Psychiatry 80:273–278.  https://doi.org/10.1016/j.pnpbp.2017.05.008 CrossRefGoogle Scholar
  4. Choi J, Joseph L, Pilote L (2013) Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev 14:232–244.  https://doi.org/10.1111/obr.12003 CrossRefPubMedGoogle Scholar
  5. Christian LM, Porter K (2014) Longitudinal changes in serum proinflammatory markers across pregnancy and postpartum: effects of maternal body mass index. Cytokine 70:134–140.  https://doi.org/10.1016/j.cyto.2014.06.018 CrossRefPubMedPubMedCentralGoogle Scholar
  6. Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71:171–186.  https://doi.org/10.1097/PSY.0b013e3181907c1b CrossRefPubMedGoogle Scholar
  7. Jha MK, Minhajuddin A, Gadad BS, Greer T, Grannemann B, Soyombo A, Mayes TL, Rush AJ, Trivedi MH (2017) Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial. Psychoneuroendocrinology 78:105–113.  https://doi.org/10.1016/j.psyneuen.2017.01.023 CrossRefPubMedGoogle Scholar
  8. Krogh J, Benros ME, Jorgensen MB, Vesterager L, Elfving B, Nordentoft M (2014) The association between depressive symptoms, cognitive function, and inflammation in major depression. Brain Behav Immun 35:70–76.  https://doi.org/10.1016/j.bbi.2013.08.014 CrossRefPubMedGoogle Scholar
  9. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22:370–379.  https://doi.org/10.1016/S0893-133X(99)00134-7 CrossRefPubMedGoogle Scholar
  10. Maes M, Verkerk R, Bonaccorso S, Ombelet W, Bosmans E, Scharpe S (2002) Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation. Life Sci 71:1837–1848CrossRefPubMedGoogle Scholar
  11. O’Brien SM, Scott LV, Dinan TG (2006) Antidepressant therapy and C-reactive protein levels. Br J Psychiatry 188:449–452.  https://doi.org/10.1192/bjp.bp.105.011015 CrossRefPubMedGoogle Scholar
  12. Pendeloski KP, Ono E, Torloni MR, Mattar R, Daher S (2017) Maternal obesity and inflammatory mediators: a controversial association.  https://doi.org/10.1111/aji.12674
  13. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131–2135CrossRefPubMedGoogle Scholar
  14. Wisner KL, Sit DKY, Moses-Kolko EL, Driscoll KE, Prairie BA, Stika CS, Eng HF, Dills JL, Luther JF, Wisniewski SR (2015) Transdermal estradiol treatment for postpartum depression: a pilot, randomized trial. J Clin Psychopharmacol 35:389–395.  https://doi.org/10.1097/jcp.0000000000000351 PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2018

Authors and Affiliations

  • Emily S. Miller
    • 1
    • 2
    • 3
  • Denada Hoxha
    • 4
  • Emily Pinheiro
    • 1
  • William A. Grobman
    • 1
    • 2
  • Katherine L. Wisner
    • 1
    • 3
  1. 1.Feinberg School of MedicineNorthwestern UniversityChicagoUSA
  2. 2.Department of Obstetrics and Gynecology, Division of Maternal Fetal MedicineNorthwestern UniversityChicagoUSA
  3. 3.Department of Psychiatry and Behavioral SciencesNorthwestern UniversityChicagoUSA
  4. 4.Wellsprings Health CliniciansChicagoUSA

Personalised recommendations